Selectis Health (OTCMKTS:GBCS – Get Free Report) is expected to post its results after the market closes on Wednesday, June 3rd. Analysts expect Selectis Health to post earnings of $0.10 per share and revenue of $8.4870 million for the quarter.
Selectis Health (OTCMKTS:GBCS – Get Free Report) last posted its earnings results on Wednesday, April 15th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.36). The company had revenue of $9.67 million during the quarter, compared to analyst estimates of $8.49 million.
Selectis Health Stock Performance
Shares of GBCS stock opened at $2.97 on Wednesday. Selectis Health has a 52 week low of $2.97 and a 52 week high of $3.61. The company’s 50 day moving average price is $3.97 and its two-hundred day moving average price is $3.00. The company has a market capitalization of $9.11 million, a P/E ratio of -8.74 and a beta of -1.07.
Selectis Health Company Profile
Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.
Recommended Stories
- Five stocks we like better than Selectis Health
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Selectis Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Selectis Health and related companies with MarketBeat.com's FREE daily email newsletter.
